LYTIR

Insider · SEC Form 4 · 10% Owner

ADAR1 Capital Management, LLC

In the 12 months to Nov 19, 2026, on the open market: bought $6.8M of TENX, NXTC, INM. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $6.8M in total; Insider sales: $0 in total.Jul: Insider purchases $1.7MAug: Insider purchases $2.5MSep: Insider purchases $777KOct: Insider purchases $1.6MNov: Insider purchases $121KDecJanFebMarAprMayJunJulAugSepOctNov$2.5M
Insider purchases above the line: $6.8MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. NXTCBought: NextCure, Inc. Nov 11, 2026 12,333 shares filed Nov 13, 2026 750,289 shares held indirectly after, as filed filing $63K
  2. NXTCBought: NextCure, Inc. Nov 6, 2026 3,662 shares filed Nov 9, 2026 737,956 shares held indirectly after, as filed filing $19K
  3. INMBought: InMed Pharmaceuticals Inc. Nov 5, 2026 2,640 shares filed Nov 9, 2026 98,297 shares held indirectly after, as filed filing $35K
  4. NXTCBought: NextCure, Inc. Nov 5, 2026 1,024 shares filed Nov 9, 2026 734,294 shares held indirectly after, as filed filing $5K
  5. NXTCBought: NextCure, Inc. Oct 27, 2026 3,553 shares filed Oct 27, 2026 733,270 shares held indirectly after, as filed filing $18K
  6. NXTCBought: NextCure, Inc. Oct 26, 2026 1,672 shares filed Oct 27, 2026 729,717 shares held indirectly after, as filed filing $8K
  7. NXTCBought: NextCure, Inc. Oct 23, 2026 5,626 shares filed Oct 27, 2026 728,045 shares held indirectly after, as filed filing $27K
  8. INMBought: InMed Pharmaceuticals Inc. Oct 23, 2026 4 shares filed Oct 27, 2026 956,584 shares held indirectly after, as filed filing $5
  9. TENXBought: TENAX THERAPEUTICS, INC. Oct 21, 2026 331,979 shares filed Oct 21, 2026 7,447,000 shares held indirectly after, as filed filing $551K
  10. TENXBought: TENAX THERAPEUTICS, INC. Oct 20, 2026 254,342 shares filed Oct 21, 2026 7,115,021 shares held indirectly after, as filed filing $406K
  11. TENXBought: TENAX THERAPEUTICS, INC. Oct 19, 2026 336,528 shares filed Oct 21, 2026 6,860,679 shares held indirectly after, as filed filing $507K
  12. INMBought: InMed Pharmaceuticals Inc. Oct 19, 2026 1,086 shares filed Oct 20, 2026 956,580 shares held indirectly after, as filed filing $1K
  13. INMBought: InMed Pharmaceuticals Inc. Oct 16, 2026 1 shares filed Oct 20, 2026 955,494 shares held indirectly after, as filed filing $1
  14. INMBought: InMed Pharmaceuticals Inc. Oct 15, 2026 984 shares filed Oct 15, 2026 955,493 shares held indirectly after, as filed filing $1K
  15. INMBought: InMed Pharmaceuticals Inc. Oct 14, 2026 8,021 shares filed Oct 15, 2026 954,509 shares held indirectly after, as filed filing $11K
  16. INMBought: InMed Pharmaceuticals Inc. Oct 13, 2026 564 shares filed Oct 15, 2026 946,488 shares held indirectly after, as filed filing $750
  17. INMBought: InMed Pharmaceuticals Inc. Oct 8, 2026 2,256 shares filed Oct 8, 2026 945,924 shares held indirectly after, as filed filing $3K
  18. INMBought: InMed Pharmaceuticals Inc. Oct 7, 2026 3,046 shares filed Oct 8, 2026 943,668 shares held indirectly after, as filed filing $4K
  19. INMBought: InMed Pharmaceuticals Inc. Oct 6, 2026 5,601 shares filed Oct 8, 2026 940,622 shares held indirectly after, as filed filing $7K
  20. INMBought: InMed Pharmaceuticals Inc. Oct 5, 2026 18,182 shares filed Oct 5, 2026 935,021 shares held indirectly after, as filed filing $24K
  21. INMBought: InMed Pharmaceuticals Inc. Oct 2, 2026 8,307 shares filed Oct 5, 2026 916,839 shares held indirectly after, as filed filing $11K
  22. INMBought: InMed Pharmaceuticals Inc. Oct 1, 2026 16,431 shares filed Oct 5, 2026 908,532 shares held indirectly after, as filed filing $22K
  23. INMBought: InMed Pharmaceuticals Inc. Sep 16, 2026 8,340 shares filed Sep 16, 2026 892,101 shares held indirectly after, as filed filing $11K
  24. INMBought: InMed Pharmaceuticals Inc. Sep 15, 2026 54,256 shares filed Sep 16, 2026 883,761 shares held indirectly after, as filed filing $70K
  25. INMBought: InMed Pharmaceuticals Inc. Sep 14, 2026 28,505 shares filed Sep 16, 2026 829,505 shares held indirectly after, as filed filing $37K
  26. TENXBought: TENAX THERAPEUTICS, INC. Sep 2, 2026 187,704 shares filed Sep 2, 2026 5,624,151 shares held indirectly after, as filed filing $338K
  27. TENXBought: TENAX THERAPEUTICS, INC. Sep 1, 2026 179,058 shares filed Sep 2, 2026 5,436,447 shares held indirectly after, as filed filing $322K
  28. TENXBought: TENAX THERAPEUTICS, INC. Aug 31, 2026 403,571 shares filed Sep 2, 2026 5,257,389 shares held indirectly after, as filed filing $723K
  29. TENXBought: TENAX THERAPEUTICS, INC. Aug 24, 2026 107,374 shares filed Aug 24, 2026 4,853,818 shares held indirectly after, as filed filing $188K
  30. TENXBought: TENAX THERAPEUTICS, INC. Aug 21, 2026 716,369 shares filed Aug 24, 2026 4,746,444 shares held indirectly after, as filed filing $1.3M
  31. TENXBought: TENAX THERAPEUTICS, INC. Aug 20, 2026 202,124 shares filed Aug 24, 2026 4,030,075 shares held indirectly after, as filed filing $360K
  32. NXTCBought: NextCure, Inc. Jul 31, 2026 36,303 shares filed Aug 3, 2026 3 transactions filing $179K
  33. NXTCBought: NextCure, Inc. Jul 30, 2026 292,850 shares filed Aug 3, 2026 6 transactions filing $1.4M
  34. NXTCBought: NextCure, Inc. Jul 29, 2026 3,410 shares filed Jul 29, 2026 2 transactions filing $17K
  35. NXTCBought: NextCure, Inc. Jul 28, 2026 6,400 shares filed Jul 29, 2026 389,856 shares held indirectly after, as filed filing $32K
  36. NXTCBought: NextCure, Inc. Jul 27, 2026 7,798 shares filed Jul 29, 2026 383,456 shares held indirectly after, as filed filing $39K
  37. INMBought: InMed Pharmaceuticals Inc. Jul 15, 2026 1,000 shares filed Jul 17, 2026 801,000 shares held indirectly after, as filed filing $2K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. INMADAR1 Capital Management, LLC filed Oct 7, 2026 Schedule 13G/A passive issuer: InMed Pharmaceuticals, Inc. filing 17.2%
  2. TENXADAR1 Capital Management, LLC filed Sep 8, 2026 Schedule 13G passive issuer: Tenax Therapeutics, Inc. filing 14%
  3. NXTCADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: NextCure, Inc. filing 15.8%
  4. KPRXADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Kiora Pharmaceuticals, Inc. filing 9.9%
  5. GRCEADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Grace Therapeutics, Inc. filing 9.9%
  6. AMANADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Amanat Acquisition Corp. filing 9.6%
  7. PLRXADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Pliant Therapeutics, Inc. filing 8.9%
  8. BOLDADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Boundless Bio, Inc. filing 8.8%
  9. VYNEADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Yarrow Bioscience, Inc. filing 8.8%
  10. RACCADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Research Alliance Corporation III filing 8.4%
  11. FRNMADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Freenome, Inc. filing 8.3%
  12. CYCNADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Cyclerion Therapeutics, Inc. filing 7%
  13. EDITADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Editas Medicine, Inc. filing 5.8%
  14. OKURADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: OnKure Therapeutics, Inc. filing 5.5%
  15. JATTADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: JATT II Acquisition Corp. filing 5.4%
  16. ADGMADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Adagio Medical Holdings, Inc. filing 5.4%
  17. RNTXADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G passive issuer: Rein Therapeutics, Inc. filing 5.3%
  18. OVIDADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Ovid Therapeutics Inc. filing 5.1%
  19. SPRBADAR1 Capital Management, LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Spruce Biosciences, Inc. filing 2.5%